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Abstract
Background: Model-independent analysis with B-spline regularization has been used to quantify
myocardial blood flow (perfusion) in dynamic contrast-enhanced cardiovascular magnetic
resonance (CMR) studies. However, the model-independent approach has not been extensively
evaluated to determine how the contrast-to-noise ratio between blood and tissue enhancement
affects estimates of myocardial perfusion and the degree to which the regularization is dependent
on the noise in the measured enhancement data. We investigated these questions with a model-
independent analysis method that uses iterative minimization and a temporal smoothness
regularizer. Perfusion estimates using this method were compared to results from dynamic 13N-
ammonia PET.
Results: An iterative model-independent analysis method was developed and tested to estimate
regional and pixelwise myocardial perfusion in five normal subjects imaged with a saturation
recovery turboFLASH sequence at 3 T CMR. Estimates of myocardial perfusion using model-
independent analysis are dependent on the choice of the regularization weight parameter, which
increases nonlinearly to handle large decreases in the contrast-to-noise ratio of the measured
tissue enhancement data. Quantitative perfusion estimates in five subjects imaged with 3 T CMR
were 1.1 ± 0.8 ml/min/g at rest and 3.1 ± 1.7 ml/min/g at adenosine stress. The perfusion estimates
correlated with dynamic 13N-ammonia PET (y = 0.90x + 0.24, r = 0.85) and were similar to results
from other validated CMR studies.
Conclusion: This work shows that a model-independent analysis method that uses iterative
minimization and temporal regularization can be used to quantify myocardial perfusion with
dynamic contrast-enhanced perfusion CMR. Results from this method are robust to choices in the
regularization weight parameter over relatively large ranges in the contrast-to-noise ratio of the
tissue enhancement data.
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Background
Dynamic contrast-enhanced cardiovascular magnetic res-
onance (DCE-CMR) is a commonly used tool for detect-
ing and quantifying reductions in myocardial blood flow
(perfusion) in patients with coronary artery disease
(CAD). The early diagnosis of CAD can provide valuable
information that may affect interventional strategies in
patients with ischemia [1]. In DCE-CMR perfusion stud-
ies, a paramagnetic gadolinium (Gd) complex is injected
into the patient while at rest and at stress–during which a
pharmacological vasodilator (adenosine) is simultane-
ously administered to the patient. Once the Gd is injected,
it flows through the heart and temporarily distributes in
the myocardium before being 'washed out' of the body.
The spatiotemporal distribution of Gd within the heart
can be measured dynamically and the resultant blood and
tissue enhancement data can be analyzed to estimate the
rate of perfusion to each region of the myocardium. A
quantitative estimate of regional myocardial perfusion
can provide an objective measure of the severity of myo-
cardial injury and may help clinicians to discriminate
regions of the heart that are at increased risk for myocar-
dial infarction.
Estimates of myocardial perfusion from DCE-CMR stud-
ies have been reported using a number of different analy-
sis methods [2-6]. Most quantitative analysis methods
require that the measured blood and tissue enhancement
data are mathematically deconvolved in order to estimate
the system impulse response function, h(t), from which
myocardial perfusion can be computed. Physiologically-
derived tracer kinetic models are often used to parameter-
ize h(t) in the deconvolution process to ensure that the
estimate of h(t) has a sensible physiologic interpretation.
Alternatively, model-independent deconvolution, based
on the central volume principle [7], can be used to esti-
mate h(t) and perfusion. Model-independent analysis is
relatively widely used with intravascular contrast agents
and has been applied with extracellular contrast agents to
quantify renal and tumor perfusion [8,9]. Also, a model-
independent approach that uses B-splines and temporal
regularization to parameterize h(t) has been developed to
estimate myocardial perfusion [4,10-12].
The objective of this work is to characterize a model-inde-
pendent deconvolution method in an inverse problem
framework that uses iterative minimization with temporal
regularization to estimate myocardial perfusion. The pro-
posed method is general, as it does not use specific mod-
els to quantify perfusion and it does not use B-splines or
other polynomials to parameterize h(t). Using simula-
tions and dynamic CMR perfusion data, we evaluate how
the choice of regularization parameter, the type of regular-
ization, and the number of iterations used in the algo-
rithm affect estimates of myocardial perfusion. As part of
this analysis, we demonstrate that the optimal regulariza-
tion weight parameter in model-independent analysis is
dependent on the contrast-to-noise ratio (CNR) of the
measured blood and tissue enhancement data. Myocar-
dial perfusion estimated with this method in five subjects
imaged with 3 T CMR was compared with a current stand-
ard for quantitative myocardial perfusion, dynamic 13N-
ammonia positron emission tomography (PET).
Methods
Model-Independent deconvolution using iterative 
minimization and temporal regularization
The central volume principle and model-independent analysis
Zierler et al. developed a theoretical framework using the
central volume principle for measuring fluid flow into
regions of tissue [7]. For biological systems that involve
fluid flow into a finite volume of tissue, the impulse
response function of the system, h(t), provides a quantita-
tive measure of the rate of flow to the tissue. According to
the central volume principle, the maximum amplitude of
h(t) is directly related to the rate of perfusion to the region
of interest, independent of physiologic parameters such as
the distribution and permeability of the vasculature
within the tissue. The primary assumption of the central
volume principle is that the impulse response function
can be described by a stationary, linear system with a sin-
gle input and a single output. In DCE-CMR perfusion
studies, the measured LV blood enhancement signal,
Cbld(t), represents the system input and the measured
myocardial tissue enhancement signal, Ctis(t), represents
the system residue. Thus, h(t) and regional myocardial
perfusion can be estimated by directly deconvolving
Cbld(t) and Ctis(t).
Jerosch-Herold pioneered the use of model-independent
deconvolution for estimating myocardial perfusion and
has used this approach in several recent studies [4,10-12].
In each of those studies, h(t) was parameterized as a sum
of weighted B-spline functionals and temporal regulariza-
tion was used to constrain the estimate of h(t). Here we
present an alternative approach for quantifying myocar-
dial perfusion with model-independent analysis, by for-
mulating a cost function in which h(t)  is estimated
directly with temporal regularization [13]. Eq (1) shows
the cost function that is minimized in this study.
||Cbld(t)  h(t) - Ctis(t)||2 + λ2 ||∇ h(t)||2 (1)
Here Cbld(t) and Ctis(t) represent the measured blood and
regional tissue enhancement curves of the LV, respec-
tively; h(t) is the system impulse response function; λ is
the regularization weight parameter; ∇ is the temporal
gradient operator; and ||*|| denotes the Euclidean norm
(L2-norm) operator. The temporal regularizing constraint
included in the cost function balances the accuracy of theJournal of Cardiovascular Magnetic Resonance 2008, 10:52 http://www.jcmr-online.com/content/10/1/52
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estimates of Ctis(t) and the temporal smoothness of h(t).
Myocardial perfusion estimates are calculated from the
maximum amplitude of h(t), scaled by the inverse of the
sampling rate of the perfusion images and the specific
gravity of the myocardial tissue (SGmyo):  Flow = max
[h(t)]/(dt*SGmyo) [7].
Determination of the regularization type and parameter
Without the inclusion of regularization, the cost function
minimization problem shown in Eq (1) may not be
unique. Noise and other inaccuracies in the measured
CMR perfusion data can exacerbate this problem. Regular-
ization techniques have been developed to condition ill-
posed and non-unique problems such as these by impos-
ing a penalty on the solution when specified conditions
are not satisfied [14,15]. The type of regularization used
can be chosen based on the class of problem being solved
or on a priori assumptions about the expected solution to
the problem. Our proposed implementation readily
accommodates multiple constraints that can help regular-
ize the solution of h(t) in the minimization process. In
this work we have chosen to include a first-order temporal
gradient constraint with a Euclidean norm (L2-norm)
operator to ensure smoothness in the estimate of h(t).
Spatial gradients could also be incorporated, and have
been explored recently in the context of DCE tumor stud-
ies using compartment modeling [16].
To ensure that there is a good trade-off between the good-
ness-of-fit of the estimated Ctis(t) curves and the overall
smoothness of h(t), L-curve analysis [17] was used to
determine the regularization weight parameter, λ, in all
five subjects. With L-curve analysis, the log of the regular-
ization norm, ||∇ h(t)||, is plotted versus the log of the
residual norm, ||Cbld(t) h(t) - Ctis(t)||, for different val-
ues of λ. The region of maximum curvature on the L-curve
represents the value of λ for which there is an optimal
trade-off between the goodness-of-fit of the estimated
Ctis(t) curve and the temporal smoothness of h(t).
Because the value of the regularization weight parameter
is dependent on the CNR of the measured blood and tis-
sue enhancement data, a different λ value was calculated
for each subject in this study. L-curve analysis was used to
determine the optimal λ values for 15 representative
regions of tissue enhancement from the 6-region data in
all five subjects at rest (three regions in five LV slices; one
slice per subject). From these λ values, an average λ value
was also calculated. Perfusion estimates were then com-
puted for the 6-region data using the optimal λ values for
each region and using the average λ value for all the
regions, to determine whether there was a significant dif-
ference between using an optimal versus a near optimal λ
value in model-independent analysis. Because the CNR of
the data measured in all five subjects in this study was
similar, an average λ value was used to estimate myocar-
dial perfusion in all five subjects from the 6-region data
(at rest and stress). Perfusion estimates computed using
the average λ value varied by less than 1% from perfusion
estimates computed using the optimal λ for each subject.
Gradient descent minimization [18] was used in the iter-
ative minimization process to compute h(t), with an ini-
tial estimate of constant h(t), h(t) = 0.001. The iterative
minimization process was repeated until the L2-norm
curve-fit error–the difference between the measured Ctis(t)
data and the estimated Ctis(t) data, computed by convolv-
ing the measured Cbld(t) with the estimate of h(t)–was less
than 5% or until n = 600 iterations were completed. A
fixed step size of γ = 1 × 10-9 was used in the minimization
process for all five subjects in the study. In most cases, the
algorithm rapidly converged on an estimate of h(t) that
was within 5% of a steady-state solution, while avoiding
oscillations and non-convergent estimates of h(t).
Simulations and CMR patient studies
Acquisition of magnetic resonance image data
Five male volunteers (age: 49 ± 17 yrs) were imaged with
3 T CMR (and dynamic 13N-ammonia PET) in this study.
The CMR and PET imaging protocols were approved by
the University of Utah Institutional Review Board and
informed consent was obtained from each subject prior to
imaging. One of the subjects had a heart transplant 15
months prior to this study; the other four subjects were
healthy with no cardiovascular risk factors. Four of the
subjects were imaged first with CMR and then with PET
approximately one month later. The fifth subject was
imaged with PET first and then with CMR six months
later. All the subjects were asked to abstain from caffeine
for at least 12 hours prior to the imaging studies and imag-
ing was always performed in the morning.
The dynamic CMR perfusion data was acquired with a Sie-
mens Trio 3 T CMR scanner (Siemens Medical Systems,
Erlangen, Germany) using a gradient echo TurboFLASH
pulse sequence with saturation recovery magnetization
preparation and a linear order phase encoding scheme.
While at rest, two subjects were imaged after being given a
0.025 mmol/kg dose of Gd-DTPA (Omniscan; Amersham
Health Inc., Princeton, NJ). Three other subjects were
given a low-dose (0.017 ± 0.005 mmol/kg) bolus injec-
tion of Gd-BOPTA (Multihance; Bracco Diagnostics Inc.,
Princeton, NJ). The change in contrast agent was due to a
change in internal policy [19,20]. In each patient study,
the contrast agent bolus was followed by a saline flush of
15 ml using a Medrad Spectris Solaris MR power injector
(Medrad, Inc., Indianola, PA) via an antecubital vein.
Also, for each subject imaged, imaging parameters were
selected in order to acquire at least three short axis (SA)
slices of the left ventricle (LV) during every heart beat.Journal of Cardiovascular Magnetic Resonance 2008, 10:52 http://www.jcmr-online.com/content/10/1/52
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Typical imaging parameters were: Saturation recovery
time~100 ms, TR~2 ms, TE~1 ms, flip angle~12°, slice~8
mm, FOV~360 × 270, resolution~1.9 mm × 2.4 mm, with
GRAPPA (R = 1.7).
Dynamic stress images were acquired approximately 10
minutes after the dynamic rest scans with the same
sequence and parameters described above. During imag-
ing, a continuous infusion of adenosine (140 μg/kg/min)
(Adenoscan; Astellas Pharma US, Inc., Deerfield, IL) was
administered to each subject via an antecubital vein to
induce vasodilation. Approximately three minutes after
the start of the adenosine infusion, a 0.025 mmol/kg dose
of Gd-DTPA followed by a saline flush of 15 ml was given
to two of the subjects, while images were acquired. The
remaining three subjects were given a low-dose (0.023 ±
0.002 mmol/kg) bolus injection of Gd-BOPTA followed
by a 15 ml saline flush. While all the rest and stress injec-
tions were assumed to be in the range of linear signal
enhancement, a reduced dose was given at rest to mini-
mize the potential effects of saturation in the later injec-
tion of Gd given at stress. All injections of Gd and saline
were administered at 5 cc/s. During the dynamic rest and
stress imaging, most patients held their breath for approx-
imately 10–20 seconds during the first-pass of contrast
agent through the LV and then breathed shallowly for the
remainder of the scan. Approximately one minute of
image data was obtained in all the subjects. Table 1 shows
the average heart rate and blood pressure measurements
taken at rest and stress for the five subjects in the study.
Magnetic resonance image processing
All CMR post-processing was performed using Matlab Ver-
sion 7.2 (The MathWorks Inc. Natick, MA). The image
frames for each slice of the LV were manually registered
for in-plane rigid body motion and endocardial and epi-
cardial contours were manually drawn to segment the LV
myocardium for perfusion analysis. Each myocardial slice
was divided into six equiangular sections and each section
was normalized to the mean pre-contrast signal of the
entire LV–which was assumed to have a uniform signal
intensity–to correct for regional CMR coil sensitivity
[21,22]. Dynamic tissue enhancement curves, Ctis(t), were
then obtained from each LV region by subtracting off the
mean value of the pre-contrast pixels in that region. A sin-
gle dynamic blood enhancement curve, Cbld(t), was
obtained from the mean change in signal intensity of a
manually selected region of the LV blood pool in a mid-
basal SA slice. Because the Cbld(t) curve used in the decon-
volution process was obtained from one LV slice, the
Ctis(t) curves from adjacent LV slices were scaled to correct
for variations in the pre-contrast signal in the myocar-
dium that may have resulted from different coil sensitivity
profiles in the adjacent slices. To reduce overestimation
effects caused by noise in the pre-contrast frames of Ctis(t)
and Cbld(t), the pre-contrast data prior to the onset of
blood and tissue enhancement was not used in the curve-
fitting process. These same steps were repeated for the pix-
elwise Ctis(t) data analysis.
For the image post-processing analysis it was assumed
that for the relatively low doses of contrast agent used, the
change in signal intensity of Cbld(t) and Ctis(t) from the
CMR perfusion images was linearly proportional to the
change in local contrast agent concentration within the LV
blood pool and the myocardial tissue [23,24]. Image
acquisition times for each frame were obtained from the
scanner in order to account for each patient's variable
heart rate or missed beats during the scan. This time-
stamp correction process has been shown to ensure more
accurate estimates of perfusion in dynamic contrast-
enhanced CMR studies [25]. Also, prior to deconvolution
Table 1: Average rest and stress heart rate (HR) and blood pressure (BP) measurements recorded from each subject during the CMR 
and PET imaging studies.
Subject 1 Subject 2 Subject 3 Subject 4 Subject 5
CMR
B a s e l i n e  H R  ( b p m ) 8 15 66 44 36 2
Baseline BP (mmHg) 168/100 112/76 143/73 153/75 98/50
Max. Stress HR (bpm) 88 90 90 68 75
Max. Stress BP (mmHg) 182/93 - 158/71 206/85 128/80
PET
B a s e l i n e  H R  ( b p m ) 8 05 65 64 35 6
Baseline BP (mmHg) 110/70 141/82 129/78 148/64 98/50
Max. Stress HR (bpm) 91 99 80 60 64
Max. Stress BP (mmHg) 120/72 159/92 122/71 164/85 112/50
Blood pressure measurements from the CMR studies were taken using a leg cuff. Blood pressure measurements from the PET studies were taken 
using an arm cuff.Journal of Cardiovascular Magnetic Resonance 2008, 10:52 http://www.jcmr-online.com/content/10/1/52
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of the Cbld(t) and Ctis(t) curves in each region of the myo-
cardium, a global time delay was estimated for each LV
slice. The global time delay was the mean delay time
between LV blood pool enhancement and local tissue
enhancement in the myocardium and was used as a fixed
parameter when estimating regional and pixelwise per-
fusion in the LV myocardium [26]. Finally, estimates of
myocardial perfusion were computed assuming the LV
myocardium has a specific gravity of 1.06 g/ml.
The effects of noise on estimates of myocardial perfusion
Because DCE-CMR perfusion images can have a higher
spatial and temporal resolution than other imaging
modalities, it may be better able to discriminate small
regions of reduced perfusion in the myocardium. How-
ever, it is unknown how well the proposed model-inde-
pendent analysis method estimates myocardial perfusion
when a non-optimal regularization parameter is used in
the analysis or when very noisy curves such as those from
single pixels in low-dose studies are evaluated.
For this analysis, several different sized regions of tissue
enhancement in each subject were selected and an opti-
mal λ value was determined for each region using L-curve
analysis. This evaluation is important because the choice
of λ using L-curve analysis is dependent on the CNR of the
blood and tissue enhancement data. For each subject, tis-
sue enhancement regions comprised of 2000, 1000, 500,
100, 50, 20, 5, and 1 pixel–each with a different CNR–
were used. The optimal λ values for each of the regions
were plotted versus the corresponding CNR of the
enhancement data to determine whether a nonlinear rela-
tionship exists between the regularization weight parame-
ter and the CNR of the data. CNR was computed as the
peak signal enhancement in each tissue region, divided by
the standard deviation of the pre-contrast signal intensity
in that same region.
The effect of λ on 6-region perfusion estimates
To evaluate how large deviations above and below the
optimal λ value affected the aggregate perfusion estimates,
several λ values, above and below the previously deter-
mined average λ value, were used to over-regularize and
under-regularize the tissue enhancement data when
model-independent deconvolution was performed. The
mean perfusion estimates and the coefficients of variation
(CV) of the perfusion estimates from the 6-region data in
all five subjects in the study (at rest) were plotted versus
the changes in λ.
The effect of λ on pixelwise perfusion estimates
Because the CNR of pixelwise enhancement data may vary
widely within a single LV slice of the myocardium, the
optimal λ values from separate pixel enhancement curves
may also be significantly different. As mentioned above,
perfusion may be overestimated if the noisy pixelwise
data is under-regularized with an inappropriate average λ
value. To evaluate the use of an average λ value for pixel-
wise enhancement data, perfusion estimates were com-
puted in each of the 40 single pixel regions described
above using the optimal λ value for each curve, and using
different average λ values for each subject, and using a sin-
gle average λ value for all five of the subjects combined.
The perfusion estimates computed using optimal λ values
for each of the 40 pixel regions were plotted versus the
perfusion estimates computed using one average λ value
for each subject or when using a single global pixelwise λ
value for all of the subjects.
Pixelwise perfusion estimates (mean ± standard devia-
tion) were compared to 6-region perfusion in each LV
slice in all five subjects. Pixelwise perfusion estimates were
computed by deconvolving the tissue enhancement data,
Ctis(t), from each image pixel in each LV slice from the
measured Cbld(t) data. In a similar manner as the 6-region
analysis, optimal λ values were determined using L-curve
analysis for eight representative pixelwise enhancement
curves in each of the five subjects at rest (eight pixels in
five LV slices; one slice per subject). An average pixelwise
λ value was also calculated. Aggregate pixelwise perfusion
estimates were computed using the average pixelwise λ
value. Pixelwise perfusion estimates were also computed
using the average 6-region λ value to determine the effects
of using under-regularizing λ value.
Comparison with dynamic 13N-ammonia PET imaging
Acquisition of PET data
On a separate day from the CMR scans, dynamic rest and
stress PET images were acquired in the same five subjects
with a GE Advance PET scanner (GE Medical Systems,
Waukesha, WI) operated in 2D mode. A 10 minute trans-
mission scan was performed using a 68Ge rod source to
measure photon attenuation and to ensure that the heart
was in the field of view. Each subject was then given a ~20
mCi injection of 13N-ammonia over 30 seconds followed
by a saline flush of 15 ml at 5 cc/s. Dynamic rest images
were acquired for 20 minutes. The temporal sampling
protocol was: 12 × 5 s, 6 × 10 s, 6 × 30 s, 5 × 1 min, 5 × 2
min. Approximately one hour after the start of the rest
scans (the half-life of 13N-ammonia is 9.97 minutes),
dynamic stress imaging was started using the same time
sampling protocol as at rest with another ~20 mCi injec-
tion of 13N-ammonia, while a continuous infusion of ade-
nosine (140 μg/kg/min) was administered for six minutes
[27].
PET image processing
Prior to reconstruction, the PET images were corrected for
photon attenuation and scatter. The images were recon-
structed to a voxel size of 4.3 mm × 4.3 mm × 4.3 mmJournal of Cardiovascular Magnetic Resonance 2008, 10:52 http://www.jcmr-online.com/content/10/1/52
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using a filtered back-projection algorithm with a Hanning
window cutoff of 1.6 cycles/cm. The image frames from
the rest and adenosine stress studies were manually regis-
tered and three SA slices of the LV myocardium were
selected to match those from the CMR studies for per-
fusion analysis. Within each SA slice, a blood pool region
of the LV was manually selected and the myocardium was
divided into six equiangular regions, similar to those used
in the CMR studies. The resulting 13N-ammonia time-
activity curves from the blood and tissue regions were fit
to a 3-compartment model, which included the effects of
radioactive decay [28,29]. The expression for the 13N
activity concentration, C(t), in each region of myocar-
dium is shown in Eq (2).
C(t) = VbCb(t) + (1 + Vb)Ct(t)( 2 )
In Eq (2), Vb is the total fraction of the blood volume in
each region of tissue, Cb(t) is the 13N activity concentra-
tion in the blood, and Ct(t) is the 13N activity concentra-
tion in each myocardial tissue. Eq(3) shows the expansion
of Ct(t) in terms of the kinetic rate constants (k1, k2, and
k3), a radioactive decay constant, λ, and a metabolite-cor-
rected arterial input function, b(t), where  is the convo-
lution operator [30,31].
In Eq (3), b(t) is the arterial input function which repre-
sents the fraction of unmetabolized and freely exchangea-
ble 13N-ammonia available in the blood, Cb(t), at time t.
For this study, metabolite correction was performed based
on average values reported in the literature [30,31].
Statistical comparison of myocardial perfusion using CMR and PET
Aggregate rest and stress myocardial perfusion estimates
(mean ± standard deviation) and the myocardial per-
fusion reserve (MPR)–the ratio of hyperemic to resting
perfusion–are reported for the five subjects imaged in the
CMR and PET studies. For each subject, perfusion esti-
mates were computed for three coronary artery territory
regions in three LV slices, based on the American Heart
Association (AHA) 16-segment model [32]. CMR per-
fusion estimates were computed using the proposed
model-independent analysis method and PET perfusion
estimates were computed using dynamic 13N-ammonia
PET with 3-compartment modeling [28,29]. Linear regres-
sion was performed and a paired Student's t-test was used
to evaluate the significance of the correlation between the
perfusion estimates using CMR and PET from all the
regions in the 16-segment model and in the territorial
AHA regions. Bland-Altman analysis was used to show
whether there was bias in the CMR and PET perfusion esti-
mates.
Results
Figure 1 shows a typical h(t) curve computed using the
proposed model-independent deconvolution method
overlaid on the corresponding measured tissue enhance-
ment curve, Ctis(t), and the estimated tissue enhancement
curve computed using h(t), for one subject in the study.
From the plot, it is noted that after a brief time delay,
while the contrast agent distributes in the myocardium,
h(t) begins with an initial maximum amplitude and then
approximates a monotonically decaying function similar
to estimates of h(t) used in other model-based deconvolu-
tion methods such as 2-compartment modeling or Fermi
function modeling. From the central volume principle,
the maximum amplitude of h(t) is related to the rate of
perfusion in the tissue: Flow = max [h(t)]/(dt*SGmyo) [7].
Figure 2 shows one L-curve plot for each of the five sub-
jects in the study. Each of the L-curves shown in Figure 2
was computed for one representative region of the 6-
region data in each of the five subjects at rest. These L-
curves were typical of the L-curves computed from multi-
ple regions of tissue enhancement in all five subjects. The
dark marker at the region of maximum curvature on each
L-curve represents the optimal value of λ that provides a
near optimal balance of the goodness-of-fit of the esti-
mated tissue enhancement curves and the temporal
smoothness of h(t), when six regions of interest per slice
were used. The five optimal regional values of λ for the
subjects imaged in the study ranged from 0.02 to 0.042.
Subsequently, an average regularization weighting param-
eter of λ = 0.03 was used for the perfusion analysis of the
6-region data for all the subjects in the study.
Perfusion estimates (at rest and stress) computed using
the single average λ value varied by ~1% from perfusion
estimates computed using the optimal regional λ values
for each subject. This small variation in perfusion esti-
mates demonstrates the robustness of the choice of λ in
the regularization process. In the iterative minimization
process, fewer than 200 iterations were required for most
of the CMR datasets to estimate h(t)  with an L2-norm
curve-fit error less than 5%. For the cases in which the L2-
norm curve-fit error never reached a steady-state value less
than 5%, a maximum of 600 iterations was used.
Figure 3 shows a plot of the optimal λ values computed
using L-curve analysis for all five subjects in the study ver-
sus the CNR of the measured tissue enhancement data in
large uniform regions of enhancement down to enhance-
ment data measured in individual pixels. For each subject
there is a nonlinear relationship between the optimal reg-
ularization weight parameter and the CNR of the meas-
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ured enhancement data. And, although the correlation
between these two variables is different for each subject,
the figure illustrates the range of optimal λ values between
subjects. The robustness of perfusion estimates to non-
optimal λ values is evaluated in Figure 4 and Figure 5.
Figure 4 shows a scatter plot of perfusion estimates in 40
single pixel regions of the myocardium (eight pixels in
five LV slices; one slice per subject) when using the opti-
mal λ value for each pixel region separately versus using
one average λ value for each subject or when using a single
average λ value for all 40 pixel enhancement regions. Per-
fusion estimates using a subject specific λ value or a single
average λ value for all the subjects were not significantly
different than the perfusion estimates computed using
optimal λ values for each pixel region separately (p = 0.54
and p = 0.14, respectively).
Figure 5 shows plots of the mean perfusion estimates
(left) and the coefficient of variation (right) of perfusion
estimates from all five subjects in the study versus changes
in the regularization weight parameter, λ. The average
optimal λ value for these perfusion estimates was λ = 0.03.
While there may be relatively large changes in perfusion
estimates across a broad range of λ values, small devia-
tions from the optimal λ value resulted in insignificant
changes in mean perfusion estimates. This demonstrates
that model-independent analysis is relatively insensitive
to deviations from the optimal regularization parameter.
The coefficient of variation of the perfusion estimates
remained nearly constant over a large range of λ values.
Regional perfusion estimates
Figure 6 shows a scatter plot of the mean rest and stress
myocardial perfusion estimates from 3 T CMR and
dynamic 13N-ammonia PET for three coronary artery ter-
ritories of the LV in all five subjects in the study. At rest
and stress, the regional perfusion estimates using 3 T CMR
were 1.03 ± 0.76 ml/g/min and 2.97 ± 1.59 ml/g/min,
respectively. The corresponding perfusion estimates at rest
and stress using dynamic 13N-ammonia PET were 0.80 ±
0.24 ml/g/min and 3.04 ± 1.14 ml/g/min. The combined
rest and stress perfusion estimates were not significantly
different between CMR and PET (p = 0.42) for coronary
artery territorial regions of the myocardium. Similarly, the
perfusion estimates were not significantly different
between CMR and PET (p = 0.11) in the individual 16-seg-
ment regions of the myocardium. Figure 7 shows a plot of
A typical h(t) curve computed using the proposed model-independent deconvolution method overlaid on the corresponding  tissue enhancement curve, Ctis(t), and the fitted Ctis(t) curve computed using h(t), for one subject in the study Figure 1
A typical h(t) curve computed using the proposed model-independent deconvolution method overlaid on the 
corresponding tissue enhancement curve, Ctis(t), and the fitted Ctis(t) curve computed using h(t), for one sub-
ject in the study.Journal of Cardiovascular Magnetic Resonance 2008, 10:52 http://www.jcmr-online.com/content/10/1/52
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the MPR values for CMR and PET imaging in the same
three AHA coronary artery territory regions [32]. The
mean MPR for 3 T CMR and PET were 3.2 ± 1.7 and 3.7 ±
0.7, respectively. The best-fit linear regression between 3 T
CMR and PET perfusion estimates was y = 0.90x + 0.24 (r
= 0.85). Table 2 gives a summary of the aggregate rest and
stress perfusion estimates and the MPR estimates using
the model-independent analysis method with 3 T CMR
and PET. Figure 8 shows a Bland-Altman plot indicating
that CMR perfusion estimates had a mean overestimation
of 0.12 ml/min/g versus PET perfusion estimates.
Pixelwise perfusion estimates
Aggregate pixelwise perfusion estimates at rest and stress
were comparable to the 6-region perfusion estimates for
all five subjects in the study (6-region: 1.0 ± 0.8 ml/min/
g and 3.0 ± 1.6 ml/min/g versus pixelwise: 1.1 ± 0.9 ml/
min/g and 2.9 ± 2.3 ml/min/g). For this comparison, dif-
ferent λ values were used for the 6-region data and the pix-
elwise data, according to the CNR of the enhancement
data. The CNR of the regional enhancement data in all
five subjects was 17.3 ± 8.5 and the CNR of the pixelwise
enhancement data was 4.8 ± 2.0. Figure 9 shows 6-region
and pixelwise perfusion maps (left and right columns,
respectively) at rest and stress (top and bottom rows,
respectively) in one LV slice from one representative sub-
ject in the study. When the average 6-region λ value was
used for the pixelwise Ctis(t) data, aggregate pixelwise per-
fusion estimates from all five subjects were 25% higher
than the 6-region perfusion estimates. This overestima-
tion was partially due to using a non-optimal λ value that
under-regularized the noisy pixelwise enhancement data.
L-curve plots for each of the five subjects in the study Figure 2
L-curve plots for each of the five subjects in the study. Each of the L-curves was computed for one representative 
region of the 6-region data in each of the five subjects at rest. These L-curves were typical of the L-curves computed from mul-
tiple regions of tissue enhancement in all five subjects. The dark marker at the region of maximum curvature on each L-curve 
represents the optimal value of λ that provides a near optimal balance of the goodness-of-fit of the estimated tissue enhance-
ment curves and the temporal smoothness of h(t). The optimal 6-region λ values for the five subjects were: λ = 0.032, 0.032, 
0.042, 0.028, 0.02.Journal of Cardiovascular Magnetic Resonance 2008, 10:52 http://www.jcmr-online.com/content/10/1/52
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Discussion
A fully model-independent deconvolution method that
uses iterative minimization and temporal regularization
has been developed and evaluated for estimating myocar-
dial perfusion in DCE-CMR perfusion studies. Temporal
regularization with a first-order gradient constraint and a
Euclidean norm (L2-norm) operator was used to ensure
temporal smoothness in the estimate of h(t). The regular-
ization overcomes the non-uniqueness of the problem
solution and ensures that h(t) has a sensible interpreta-
tion that is not dominated by noise. This model-inde-
pendent analysis method is general, as it does not rely on
the assumptions of model-based analysis, which may
oversimplify the kinetics of contrast agent transfer in the
myocardium. And although this iterative method may not
be as fast as linearized methods for estimating perfusion
[4], it only requires 2–3 seconds to estimate perfusion in
six regions in each LV slice (in Matlab), which is fast
enough for practical use in most clinical perfusion studies.
Though a direct comparison of this proposed model-inde-
pendent method and a B-spline method [4] was not the
focus of this study, in our preliminary work we did com-
pare our results with those obtained using a parameter-
ized B-spline method. For those comparisons, the
maximum amplitudes of the h(t) curves in 16 regions of
the heart in all five subjects were not significantly different
for the two methods (p = 0.16). Since our implementation
of the B-spline method used truncated singular value
decomposition (SVD), rather than generalized SVD as it
has been published [4], it is not known how similar the
results from our method and the original B-spline method
are. In general, we found that the iterative method using a
model with a larger number of degrees of freedom and the
B-spline model, which assumes a more specific parame-
terization of h(t), could both adequately represent the tis-
sue enhancement data and give results similar to the
widely accepted gold standard dynamic PET for non-inva-
sively quantifying myocardial perfusion.
Comparison of perfusion estimates from CMR and PET
Myocardial perfusion estimates using the proposed
model-independent method with 3 T CMR perfusion data
correlated with perfusion estimates from dynamic 13N-
ammonia PET (y = 0.90x + .24, r = 0.85). These perfusion
estimates are comparable to published results in three
A plot of the optimal λ values computed using L-curve analysis versus the CNR of measured tissue enhancement data in large  uniform regions of enhancement down to data measured in an individual pixel in each of the five subjects Figure 3
A plot of the optimal λ values computed using L-curve analysis versus the CNR of measured tissue enhance-
ment data in large uniform regions of enhancement down to data measured in an individual pixel in each of 
the five subjects. For each subject there is a nonlinear relationship between the optimal regularization weight parameter and 
the CNR of the measured enhancement data. And although the correlation between these two variables is different for each 
subject, the figure illustrates the importance of determining an optimal λ value according to the CNR of the measured data.Journal of Cardiovascular Magnetic Resonance 2008, 10:52 http://www.jcmr-online.com/content/10/1/52
Page 10 of 15
(page number not for citation purposes)
pigs (~1 ml/min/g and ~3.5 ml/min/g for rest and stress,
respectively), in which a slightly higher dose of contrast
agent (0.04 mmol/kg) and model-independent analysis
with B-splines was used [4]. More recently, another group
compared perfusion estimates from CMR and PET in
humans using an even larger dose of contrast agent (0.08
mmol/kg) with a calibrated inversion recovery Turbo-
FLASH pulse sequence [33]. Using this method, they
found rest and stress Ktrans estimates to be slightly lower
than the perfusion estimates reported here. However, it is
difficult to directly compare results from that study
because of the different pulse sequence used, the larger
dose of Gd, and because compartment modeling was used
to estimate Ktrans, which is an index of blood flow that is
often corrected by an assumed extraction fraction.
The relatively small differences in perfusion estimates
between the 3 T CMR studies and the dynamic PET studies
may partially be due to nonlinear variations in CMR sig-
nal enhancement versus the doses of contrast agent used
in the studies. This nonlinear relationship between
changes in image signal intensity and contrast agent con-
centration at high concentrations of Gd has been widely
researched [23,24]. Some groups have concluded that the
assumption of linearity in the measured Cbld(t) data may
only be valid for contrast agent doses as low as 0.005–
0.01 mmol/kg [34-37]. Other groups have demonstrated
that contrast agent doses as high as 0.025–0.04 mmol/kg
can be used for quantifying myocardial perfusion in DCE-
CMR studies [4,5,38], though this depends on the specific
imaging sequence used and imaging parameters such as
the saturation recovery time. Doses of ~0.017 mmol/kg
for Gd-BOPTA and ~0.025 mmol/kg for Gd-DTPA were
used here.
Another possibility regarding the higher values of CMR
perfusion versus PET may be due to the use of 3-compart-
ment modeling to estimate perfusion with PET. The 3-
A scatter plot of perfusion estimates in 40 single pixel regions of the myocardium (eight pixels in five LV slices; one slice per  subject) when using the optimal λ value for each pixel region separately versus using one average λ value for each subject or  when using a single average λ value for all 40 pixel enhancement regions Figure 4
A scatter plot of perfusion estimates in 40 single pixel regions of the myocardium (eight pixels in five LV slices; 
one slice per subject) when using the optimal λ value for each pixel region separately versus using one average 
λ value for each subject or when using a single average λ value for all 40 pixel enhancement regions. Perfusion 
estimates using five average λ values or a single average λ value for all the subjects were not significantly different than the per-
fusion estimates computed using optimal λ values for each pixel region separately (p = 0.54 and p = 0.14, respectively).Journal of Cardiovascular Magnetic Resonance 2008, 10:52 http://www.jcmr-online.com/content/10/1/52
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compartment model explicitly accounts for the fraction of
signal enhancement in Ctis(t) caused by the myocardial
vasculature, Vb, while model-independent analysis does
not. The fact that Vb is also used in 3-compartment mod-
eling of the PET data to correct for the (large) partial vol-
ume effects of LV blood pool enhancement within the
myocardium may also have effects.
The aggregate CMR MPR was 16% less than the PET MPR
(3.2 ± 1.7 for CMR versus 3.7 ± 0.7 for PET), which is in
somewhat better agreement than the perfusion estimates
at rest. While the differences in absolute measures of rest
and stress perfusion may be due to the small number of
subjects imaged in the study, the similar MPR values for
CMR and PET may partially be due to the cancellation of
systematic effects that occur at rest and stress [39]. Further-
more, a reduced CMR MPR compared to PET has also
been reported by other groups [33,40,41]. In those studies
the mean CMR MPR values in healthy subjects ranged
Plots of the mean perfusion estimates (left) and the coefficients of variation (CV) (right) of perfusion estimates from all five sub- jects in the study versus changes in the regularization weight parameter, λ Figure 5
Plots of the mean perfusion estimates (left) and the coefficients of variation (CV) (right) of perfusion estimates 
from all five subjects in the study versus changes in the regularization weight parameter, λ. The average optimal 
λ value for these perfusion estimates was λ = 0.03. While there may be relatively large changes in perfusion estimates across a 
broad range of λ values, small deviations from the optimal λ value result in insignificant changes in mean perfusion estimates. 
This demonstrates that model-independent analysis is relatively insensitive to small deviations from the optimal regularization 
parameter. The coefficients of variation of the perfusion estimates remained nearly constant over a large range of λ values.
Table 2: Aggregate rest and stress perfusion estimates and MPR values for all five subjects imaged with 3 T CMR and dynamic 13N-
ammonia PET.
Rest Perfusion (ml/min/g) Stress Perfusion (ml/min/g) MPR
CMR 1.03 ± 0.76 2.97 ± 1.59 3.2 ± 1.7
PET 0.80 ± 0.24 3.04 ± 1.14 3.7 ± 0.7
These results were computed from the mean perfusion estimates in three coronary artery territory regions in three short-axis slices of the LV of 
each subject.Journal of Cardiovascular Magnetic Resonance 2008, 10:52 http://www.jcmr-online.com/content/10/1/52
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between 2.1 and 2.5, while the mean PET MPR values
ranged between 2.7 and 4.3.
Effects of the regularization weight parameter on 
perfusion estimates
Estimates of myocardial perfusion using model-inde-
pendent analysis are dependent on the choice of the regu-
larization weight parameter, which increases nonlinearly
to handle large decreases in the CNR of the measured tis-
sue enhancement data. This result is illustrated in Figure
3, and was further demonstrated by using the optimal λ
value from the 6-region analysis to estimate perfusion in
the much noisier pixelwise enhancement data. When the
λ value from the 6-region analysis was used with the low
CNR pixelwise data, perfusion estimates were 25% higher
than the 6-region flows due to the under-regularization of
the noisy pixelwise data. When an average optimal pixel-
wise λ value was used, the aggregate perfusion estimates
were similar to those in the 6-region analysis. This finding
is unique to model-independent analysis. Other model-
based deconvolution methods such as compartment
modeling or Fermi function analysis do not require model
parameter tuning depending on the CNR of the measured
enhancement data.
When the regularization weight parameter was increased
slightly above or below the optimal λ value from L-curve
analysis, the mean aggregate perfusion estimates only
slightly decreased and increased, respectively (see Figure
5). Similarly, the coefficient of variation of the aggregate
perfusion results remained nearly constant across a broad
range of λ values. These findings suggest that estimates of
regional perfusion are relatively insensitive to small varia-
tions (and even large variations) in the optimal λ value
and that the large standard deviations in resting perfusion
estimates are not likely due to over-regularization or
under-regularization of the enhancement data.
For pixelwise enhancement data with a relatively wide
range of CNR values, an average λ value may be suitable
for estimating perfusion. As shown in Figure 4, perfusion
estimates in 40 pixel enhancement regions (eight pixels in
five LV slices; one slice per subject) were not significantly
different when average λ values from each subject were
used (p = 0.54) or when a single average λ value was used
for all five subjects (p = 0.14).
Figure 4 and Figure 5 also reveal a trend that regions of tis-
sue with more blood flow (during stress imaging, for
example) are more likely to be underestimated than
regions of low blood flow. This effect is partially caused by
over-regularization of the higher flow data, which typi-
cally has a higher CNR. While perfusion estimates are rel-
A scatter plot of the mean rest and stress myocardial per- fusion estimates from 3 T CMR and dynamic 13N-ammonia  PET for three coronary artery territories of the LV in all five  subjects in the study Figure 6
A scatter plot of the mean rest and stress myocardial 
perfusion estimates from 3 T CMR and dynamic 13N-
ammonia PET for three coronary artery territories 
of the LV in all five subjects in the study.
A plot of the CMR and PET MPR values for all five subjects in  the study for three coronary artery territory regions of the  LV myocardium Figure 7
A plot of the CMR and PET MPR values for all five 
subjects in the study for three coronary artery terri-
tory regions of the LV myocardium. The mean MPR for 
3 T CMR and PET were 3.2 ± 1.7 and 3.7 ± 0.7, respectively.Journal of Cardiovascular Magnetic Resonance 2008, 10:52 http://www.jcmr-online.com/content/10/1/52
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atively insensitive to small changes in CNR, in which an
average λ value is suitable for model-independent analy-
sis, large differences in CNR require different regulariza-
tion weight parameters.
Conclusion
This work demonstrates that a model-independent analy-
sis method that uses iterative minimization and temporal
regularization can be used to estimate myocardial per-
fusion in DCE-CMR studies. The method is flexible to
accommodate different types of spatial or temporal regu-
larization, which can reduce the effects of motion and
noise in the blood and tissue enhancement data.
Estimates of myocardial perfusion using model-inde-
pendent analysis are dependent on the choice of the regu-
larization weight parameter, which increases nonlinearly
to handle large decreases in the CNR of the measured tis-
sue enhancement data. However, a fixed average λ value
can give good results for fitting time curves with similar
but not identical CNR values, such as found with pixel-
wise perfusion estimates.
Perfusion estimates with this method in five normal sub-
jects imaged with 3 T CMR correlated with perfusion esti-
mates from dynamic 13N-ammonia PET (y = 0.90x + 0.24,
r = 0.85), a current standard for non-invasively quantify-
ing myocardial perfusion. It must be noted however, that
the results and conclusions drawn from this study are lim-
ited because of the small number of subjects imaged.
Additional studies in normal and diseased patients are
needed to further evaluate and validate the accuracy of
this method.
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